Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses

Performance of CAST (Cellular Antigen Stiumulation Test)in Patients With Wasp Venom Allergy. Evaluation of Neutralizing IgG Subclasses

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00794287

Enrollment

Registered

2008-11-20

Start date

2009-01-31

Completion date

Unknown

Last updated

2015-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wasp Venom Allergic Patients

Brief summary

To determine which subclass of IgG in the serum of patients undergoing SIT against wasp venom is able to neutralize the allergen, and therefore to prevent a positive CAST

Interventions

OTHERTaking blood samples

No intervention is done. Only blood samples are taken.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* male and female patient with allergy to wasp venom grade III and IV according to H.L. Müller * 18-75 years * planned SIT against wasp venom or finished 5 years SIT against wsp venom (10/10)

Exclusion criteria

* oral corticosteroids * chromogycin * ketotifen * immunosuppressive drugs within the last 2 years

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026